Position
Fidelity in Jazz Pharmaceuticals Plc
Back to the book · All holders of JAZZ
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $118.2M$189.05 → $240.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 800.9K | $136.2M | — | — | — | 0.0% |
| Q1 2026 | 2.28M | $430.2M | $189.05 | $15.3M | $278.8M | 0.0% |
| Q2 2026 | 4.61M | $1.11B | $240.97 | $118.2M | $562.3M | 0.0% |